CRBU
NASDAQ
US
Caribou Biosciences, Inc. - Common Stock
$1,94
▼ $-0,05
(-2,51%)
Vol. 1.1M
4
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$148.6M
ROE
-80,8%
Margine
-1690,5%
D/E
0,00
Beta
2,68
52W
$1–$4
Consenso Wall Street
15 analisti · Apr 20265
Acquisto forte
9
Compra
1
Mantieni
0
Vendi
0
Vendita forte
93,3%
Rating Compra
Grafico dei Prezzi
Titoli simili
ANIK
Anika Therapeutics Inc
$138.6M
SABS
SAB Biotherapeutics Inc
P/E 9,5
$178.0M
ELTX
Elicio Therapeutics Inc
$139.2M
ZNTL
Zentalis Pharmaceuticals Inc
$97.5M
MGNX
MacroGenics Inc
$101.8M
TNXP
Tonix Pharmaceuticals Holding Corp
$199.7M
CRBP
Corbus Pharmaceuticals Holdings Inc
$142.9M
GALT
Galectin Therapeutics Inc
$268.2M
ACHV
Achieve Life Sciences Inc
$264.6M
Utili
Tasso di battuta: 75,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $-0,32 | $-0,28 | +$0,04 |
| Set 2025 | $-0,37 | $-0,30 | +$0,07 |
| Giu 2025 | $-0,40 | $-0,58 | $-0,18 |
| Mar 2025 | $-0,45 | $-0,43 | +$0,02 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $2.1M | $2.4M | $2.7M | $2.2M | $3.9M |
| Utile netto | — | -$35.5M | -$40.0M | -$54.1M | -$27.5M | -$26.5M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -71.6% | -71.6% | -71.6% | -71.6% | -80.8% | -80.8% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -2028.4% | -1800.9% | -1800.9% | -1800.9% | -1690.5% | -1690.5% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.66 | 6.66 | 6.66 | 6.66 | 5.54 | 5.54 |
Rapporti chiave
ROA (TTM)
-62,7%
P/S (TTM)
15,99
P/B
0,6
EPS (TTM)
$-1,70
CF/Share
$-1,36
Crescita ricavi 3A
+1,4%
52W High
$3,54
52W Low
$0,66
$0,66
Intervallo 52 settimane
$3,54
Salute finanziaria
Flusso di cassa libero
-$20.6M
Debito netto
$14.9M
Liquidità
$12.4M
Debito totale
$27.2M
Aggiornato al Dic 31, 2025
Як CRBU виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка CRBU vs аналоги Biotechnology
P/E
—
▼
0%
sotto
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
16,0
▲
24%
sopra
peer
(12,9)
vs Peer
vs Settore
Più costoso
P/B
0,6
▼
77%
sotto
peer
(2,5)
vs Peer
vs Settore
Sottovalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість CRBU vs аналоги Biotechnology
ROE
-80,8%
▼
20%
sotto
peer
(-67,3%)
vs Peer
vs Settore
Sotto media
Net margin
-1690,5%
▼
490%
sotto
peer
(-286,8%)
vs Peer
vs Settore
Debole
Валова маржа
—
▼
0%
sotto
peer
(78,6%)
vs Peer
vs Settore
In linea
ROA
-62,7%
▼
34%
sotto
peer
(-46,7%)
vs Peer
vs Settore
Debole
Фінансове здоровʼя CRBU vs аналоги Biotechnology
D/E ratio
0,0
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
Debito basso
Поточна ліквідність
5,5
▲
25%
sopra
peer
(4,4)
vs Peer
vs Settore
Sotto media
Beta
2,7
▲
177%
sopra
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів CRBU
CRBU
Mediana peer
Industria
CRBU прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
CRBU vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
KELLY TIMOTHY P
Chief Technology Officer · Feb 25
6228 shs
MCCLUNG BARBARA G
Officer · Feb 24
6938 shs
KELLY TIMOTHY P
Chief Technology Officer · Feb 24
3147 shs
KHAN RUHI AHMAD
Officer · Feb 24
6938 shs
ALBERTSON TINA M.
Officer · Feb 24
1066 shs
MCCLUNG BARBARA G
Officer · Feb 20
45000 shs
HAURWITZ RACHEL E. PH.D.
Chief Executive Officer · Feb 20
151700 shs
KELLY TIMOTHY P
Chief Technology Officer · Feb 20
45000 shs
RYALI SRIRAM
Chief Financial Officer · Feb 20
55000 shs
KHAN RUHI AHMAD
Officer · Feb 20
45000 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 15,81%Pfizer Inc
4,85%
$8.3M
Vanguard Group Inc
4,45%
$7.7M
Kynam Capital Management, LP
2,59%
$4.5M
Blackrock Inc.
2,22%
$3.8M
Renaissance Technologies, L…
1,70%
$2.9M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora